US Pharma MarketingShifting more responsibility for procedure costs to hospitals is unlikely to pressure prices for orthopedic implants, CEOs said.
Ortho firms unfazed by Medicare joint replacement changes
Ortho firms unfazed by Medicare joint replacement changes is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: MedTech Dive